Accolade (ACCD) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to loss of $0.52 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 27.08%. A quarter ago, it was expected that this company would post a loss of $0.11 per share when it actually produced a loss of $0.10, delivering a surprise of 9.09%. Over the last four quarters, the company has surpassed cons ...

业绩总结 - Accolade Inc. 在2024财年预计实现4.6亿至4.75亿美元的营收[28] - Accolade Inc. 在2025财年预计实现1,500万至2,000万美元的调整后息税折旧及摊销前利润（EBITDA）[28] - Accolade Inc. 在过去几年中保持了30%的年复合增长率[30] - Accolade Inc. 在过去几年中实现了稳健的财务增长，朝着盈利目标取得进展[30] 用户数据 - Accolade Inc. 在过去几年中不断扩大可寻址市场，目前已拥有超过1400家客户[29] - FY24年有超过1200家客户[31] - FY24年没有任何一个客户占据5%以上的份额[31] 未来展望 - 财报中提到了长期目标，调整后的毛利率目标为50-55%[32] - 调整后的销售和市场费用占营收的比例目标为15-20%[33] - 调整后的总务和行政费用占营收的比例目标为7-9%[34] - 调整后的EBITDA利润率目标为15-20%[35] 新产品和新技术研发 - Accolade Inc. 在过去几年中推出了智能提供者匹配、COVID应对护理、整合护理等创新项目[28] 市场扩张和并购 - Accolade Inc. 在2020年7月进行了首次公开募股（IPO），随后在2020年10月和2021年3月进行了跟进发行和可转债发行[28] 负面信息 - 调整后的毛利、毛利率和EBITDA有一定的局限性，因为它们排除了某些非现金费用的影响[40]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________________________ FORM 10-Q ______________________________________________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39348 ACCOLA ...

Exhibit 99.1 Accolade Announces Results for Fiscal First Quarter 2025 SEATTLE, June 27, 2024 -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024. “Accolade's physician-led advocacy approach to solving the Physician Gap is increasing accessibility to healthcare and improving outcomes for the millions of lives we service. We will continue to push our leadership in Healthcare AI and a proven engagement model that is driving sustainable and profitab ...

SEATTLE, June 27, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024. “Accolade's physician-led advocacy approach to solving the Physician Gap is increasing accessibility to healthcare and improving outcomes for the millions of lives we service. We will continue to push our leadership in Healthcare AI and a proven engagement model that is driving sustainable and profitable growth. Our focus remains on delivering a superior ...

SEATTLE, June 27, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024. “Accolade's physician-led advocacy approach to solving the Physician Gap is increasing accessibility to healthcare and improving outcomes for the millions of lives we service. We will continue to push our leadership in Healthcare AI and a proven engagement model that is driving sustainable and profitable growth. Our focus remains on delivering a superior ...

SEATTLE, June 12, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal first quarter 2025 financial results on Thursday, June 27, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-register by clicking here (https://register.vevent.com/register/BI651ad635 ...

SEATTLE, June 12, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal first quarter 2025 financial results on Thursday, June 27, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-register by clicking here (https://register.vevent.com/register/BI651ad635 ...

The partnership combines Noom's best-in-class content and coaching with Accolade's advanced primary care physicians SEATTLE, May 21, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today that Noom has joined Accolade's Trusted Partner Ecosystem to provide customers with a comprehensive solution for weight loss and metabolic health, including support for GLP-1s and other anti-obesity medications. In addition to the standard integrated features that drive appropriate Trusted Partner utilization, ...

财务数据和关键指标变化 - 公司在第四财季实现了约1.25亿美元的收入,同比增长30%。这主要得益于业绩良好、新客户启动收入、使用量相关访问和案例费收入以及直接面向消费者的虚拟初级护理业务的增长 [25][26] - 第四财季调整后EBITDA为1850万美元,创下公司历史新高。全年收入为4.143亿美元,调整后EBITDA亏损750万美元 [26] - 截至第四财季末,现金、现金等价物和有价证券总额为2.37亿美元,较上一季度增加700万美元 [28] 各条业务线数据和关键指标变化 - 公司的年度经常性收入(ARR)在上一财年增长约20%,反映了企业、政府和医疗计划业务的强劲势头 [29] - 直接面向消费者的业务在上一财年再次实现20%以上的增长,并在公司的产品组合中保持高度差异化 [10][20] - 公司将"平台连接收入"定义为与导航平台相关的访问费、专家医疗意见案例费和合作伙伴生态系统收入。这部分收入在过去两个财年里大约翻了一番,并预计在未来将继续大幅增长 [40][41][42] 各个市场数据和关键指标变化 - 公司正在与医疗保险公司建立更深入的合作关系,将公司的某些功能嵌入到他们自己的雇主产品中。比如与加州蓝盾的"Virtual Blue"合作,取得了出色的成果,整体人群成本降低8%-10%,急诊就诊量下降11% [14] - 最近,阿肯色州蓝十字蓝盾也推出了一款由公司导航平台驱动的雇主产品,客户可选择增加Accolade Care或二次意见服务 [15] - 公司预计未来几年内,与医疗保险公司的合作关系(包括转售安排和基于公司核心功能的新产品合作)将成为业务增长的重要引擎 [15] 公司战略和发展方向及行业竞争 - 公司CEO表示,过去几年市场发生了根本性变化,成功需要平衡增长和盈利的思维模式,专注于执行力、纪律和盈利能力 [6] - 公司的导航平台与自有的初级护理和专家医疗意见服务以及可信赖的合作伙伴无缝集成,这对雇主来说尤其有吸引力,与竞争对手有所不同 [12] - 公司利用人工智能和技术投资显著提高了过去几年的盈利能力 [13] - 公司直接面向消费者的虚拟初级护理和心理健康服务持续以高于市场的速度增长,具有很强的差异化优势 [16][17][18][19][20] 管理层对经营环境和未来前景的评论 - 公司CEO表示,从未如此看好公司所在的市场,以及公司的规模和杠杆模式,以及执行愿景的团队 [21] - 公司CFO表示,公司正在向实现全年盈利调整后EBITDA的目标迈进,这反映了业务的多元化和预测性 [50] - 公司预计2025财年收入增长16%-21%,调整后EBITDA占收入3%-4% [34][37] 问答环节重要的提问和回答 问题1 **Jailendra Singh 提问** 询问了绩效担保(PG)与平台连接收入之间的关系,以及未来PG设计是否会更多地关注合作伙伴的参与度或注册情况 [53][54] **Rajeev Singh 和 Steve Barnes 回答** 回应说,推动合作伙伴生态系统的利用一直是客户用来评估和补偿公司的关键绩效指标之一。这与公司的长期战略方向一致。未来PG设计不会发生重大变化 [54][55][56][57] 问题2 **Stephanie Davis 提问** 询问了公司在现有客户群中的附加率和交叉销售机会,是否有任何客户的收入上限或附加率的基准 [59] **Rajeev Singh 回答** 解释说,公司正在同时关注新客户获取和现有客户的平台连接收入增长。有一个典型客户案例,通过增加使用公司的各种服务,其PEPM收入增长了约50% [60][61][62] 问题3 **Ryan Daniels 提问** 询问公司如何通过营销和内部数据分析来推动使用量驱动的平台连接收入的增长 [64] **Rajeev Singh 和 Steve Barnes 回答** 强调公司利用数据分析和智能化平台,有针对性地将成员引导到合适的护理服务,这是推动使用量增长的关键。同时,与合作伙伴的整合也是增加使用量和相关收入的重要驱动因素 [65][66]